Navigation Links
Maxygen Reports Third Quarter 2007 Financial Results
Date:11/1/2007

REDWOOD CITY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY) today reported financial results for the quarter ended September 30, 2007. Maxygen reported a net loss of $14.7 million, or $0.40 per share, for the third quarter 2007 as compared to a net loss of $10.7 million, or $0.30 per share, for the comparable period in 2006. The net loss reflects continued investment in the company's lead program, MAXY-G34, for the treatment of chemotherapy-induced neutropenia.

"Our Phase II trial of MAXY-G34 in breast cancer patients is accelerating as we continue to initiate additional sites," said Russell Howard, chief executive officer of Maxygen. "We are also pleased to report that our MAXY-VII program for hemophilia is moving quickly and according to plan towards a European CTA filing in the first half of 2008."

"During the third quarter we announced a hold on our MAXY-alpha program, which is partnered with Roche," continued Dr. Howard. "We plan to provide an update on the status of this program as soon as information becomes available. Because the program is fully funded by Roche, our near-term financials are unaffected by the hold."

Excluding the impact of non-cash stock compensation expense under SFAS 123( R ), Maxygen reported a non-GAAP net loss (see Footnote A) of approximately $13.0 million, or $0.35 per share, in the third quarter of 2007, compared to a non-GAAP net loss of approximately $8.9 million, or $0.25 per share, in the third quarter of 2006.

Revenue for the third quarter of 2007 was $1.0 million, compared to $4.2 million for the same period in 2006. The decrease was primarily due to the discontinuation in the second quarter of this year of Maxygen's partnership wit
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...menopause to postmenopause , , MONTVALE, N....y and intensity of vasomotor symptoms is a challen...nt and The Journal of Family Practice have rece...toms: Managing the transition from perimenopause t...or, MD, CM and Lee P. Shulman, MD, discuss the ben...
(Date:12/2/2008)...Applied BioSciences has turned to MBI Internationa...cial viability of an important bio-based product l... gap between research and commercialization throug...es. MBI’s unique “Collaborative De-Ris...ological uncertainties, which impede new technolog...
(Date:12/2/2008)...wire/ -- GeneGo, Inc., the leading systems biology...ecome a certified GeneGo Center of Excellence. Bur... to GeneGo,s MetaCore data analysis suite, trainin...a world-class biomedical research facility running...ny departments, including research in cancer, stem...
(Date:12/2/2008)...wire/ -- Intradigm Corporation, a leading,develop...herapeutics, today,announced the issuance of Unit... Compositions for Controlling Efficacy of RNA Sile... seminal research of Philip Zamore, Ph.D., the,Gr... Professor of Biochemistry,& Molecular Pharma...
Breaking Biology Technology: DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product 2The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 3
... Wis. - This summer, venture investors deployed m...s Wisconsin, a total that may bode well for improv...ile it is difficult to draw firm conclusions from ...ld indicate that technologically innovative compan...ase of capital in 2006. , ,"With the growth of the...
... Wis. - The Madison-based National Stem Cell Ban...tem cells from the University of California-San F...available on the federal registry. , ,Beth Donley,...ute , which houses the stem cell bank, said the or...ave all 21 federally approved lines. , ,"We,re ver...
...Wis. - The Center for Advanced Technology and In...ogy-based economic development programs. , ,An awa...uncil recognizes CATI,s work in developing a $40 ...uch as Kraft Foods , S.C. Johnson , and Boeing ...ments, five company product line expansions, and t...
... Wis. - Genetically engineered mice are very expe...ny has developed a method for producing similarly ...io Corp. , a privately-held biopharmaceutical firm...urdles associated with producing modified mice at ... animals instead. , ,Mirus has begun using its spe...
Other Biology Technology:Summer venture investments total $18 million for Wisconsin start ups 2Summer venture investments total $18 million for Wisconsin start ups 3Summer venture investments total $18 million for Wisconsin start ups 4Nation's only stem cell bank will receive UC-San Francisco cell line 2Mirus provides low-cost way to modify genes 2
(Date:12/2/2008)...ywhere else in the world. This is having a major i...nvironment and effect of cities on rural areas. On...ca,s history is being over-looked. , Joy Clancy ...blem in the current issue of the African Journal ...the African population was rural, today 38% live i...
(Date:12/2/2008)...tion due to climate change, pollution and human ac... providing satellite data of the region for the la...ion with ESA,s future missions will be key in impl...icy called ,The European Union and the Arctic Regi...n the region such as the opening up of long-sought...
(Date:12/1/2008)...spread consumption advisories and uncertainty amon...w researchers at North Carolina State University h...d regulators around the country predict which area... a breakthrough that should help officials addres...es for specific water bodies and fish species. , ...
(Date:12/1/2008)...old a colloquium to examine what lies ahead in evo...isms. Leading researchers and students will discus...tion and even evolution from the perspectives of e...ity informatics dealing with microbes, plants, and...he event will take place at the Arnold and Mabel B...
Breaking Biology News(10 mins):ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2American Council on Exercise Offers 10 Tips for Surviving the Holidays 2847 1American Council on Exercise Offers 10 Tips for Surviving the Holidays 2847 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 1IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 3Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 1Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 2Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 1Clarient Names Michael J Pellini M D Chief Operating Officer 2845 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 4
...approach animals in the wild more easily from a ca...tor" tuned to the visual movements of an approachi...logist Niko Troje. , "We believe this visual filt...are propelled by the motion of their feet and the ...arch Chair in Vision and Behavioural Sciences. ,...
...h at the University of Illinois atUrbana-Champaign...irst sequence of the swine genome to be completed ... the U.S. Department of Agriculture announced toda... , Lawrence B. Schook, a professor of animal scien...al Swine Genome Sequencing Consortium, will head t...
...stainable agricultural production, what is require...es to the nitrates that predominate in agricultura...ty. The current use of nitrates as a nitrogenated ...environmental problems such as the contamination o...re are also health problems such as deficiencies i...
... is not associated with an increased risk of cance...ue of the Journal of the National Cancer Institu...breast cancer risk and an increased lung cancer ri...s and smoking habits of the women in the study rat... authors conclude. , Past reports have examined th...
Other Biology News:Animal brains 'hard-wired' to recognize predator's foot movements, Queen's study suggests 2Illinois pig to make history as source of first complete swine genome 2Alternatives to the use of nitrate as a fertiliser 2Alternatives to the use of nitrate as a fertiliser 3Breast implants not associated with cancer risk, study reports 2
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis.
Request Info
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution.
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates.
Biology Products: